Sign in

CIK 0001390478

  • Non-accelerated filer
  • Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-200-5278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$716,682
in 3 filings

Net −$716,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2013-01-29 KRIEGSMAN STEVEN A Director Grant or award · Stock Option (right to buy) +50,000 50,000
2013-01-29 Hillsberg Sanford Director Grant or award · Stock Option (right to buy) +50,000 50,000
2013-01-29 Dunlap Ryan Principal Accounting Officer Grant or award · Stock Option (right to buy) +40,000 40,000
2012-12-31 Ahn Mark J President & CEO Other acquisition +7,668 $1.30 $10K 100,246
2012-12-31 SCHWARTZ MARK W. EVP, Chief Operating Officer Other acquisition +7,668 $1.30 $10K 462,688
2012-12-31 Dunlap Ryan Principal Accounting Officer Other acquisition +1,246 $1.30 $2K 1,246
2012-11-02 Hillsberg Sanford Director Gift −20,000 136,376
2012-07-10 SCHWARTZ MARK W. EVP Chief Operating Officer Other acquisition +21,902 $0.40 $9K 461,809
2012-07-10 Ahn Mark J President & CEO Other acquisition +31,289 $0.40 $12K 92,578
2012-06-15 SCHWARTZ MARK W. EVP Chief Operating Officer Grant or award +89,322 439,907
2012-06-15 Hillsberg Sanford Director Grant or award +31,966 156,376
2012-06-15 MAZANET ROSEMARY Chief Medical Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2012-01-12 Hillsberg Sanford Director Grant or award · Stock Option (right to buy) +50,000 50,000
2012-01-12 Nisi Rudolph Director Grant or award · Stock Option (right to buy) +50,000 50,000
2012-01-12 Chin Richard Director Grant or award · Stock Option (right to buy) +50,000 50,000
2012-01-12 GALLIKER STEPHEN S Director Grant or award · Stock Option (right to buy) +50,000 50,000
2012-01-12 KRIEGSMAN STEVEN A Director Grant or award · Stock Option (right to buy) +50,000 50,000
2012-01-12 SCHWARTZ MARK W. EVP Chief Operating Officer Grant or award · Stock Option (right to buy) +200,000 200,000
2012-01-12 Ahn Mark J President & CEO Grant or award · Stock Option (right to buy) +400,000 400,000
2011-12-31 SCHWARTZ MARK W. EVP Chief Operating Officer Other acquisition +12,924 $0.40 $5K 350,585

Page 19 of 29 · 580 trades